The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus

被引:45
作者
Delate, T
Coons, SJ
机构
[1] Univ Arizona, Hlth Sci Ctr, Coll Pharm,Grad Program, Dept Pharmaceut Sci, Tucson, AZ 85721 USA
[2] Univ Arizona, Coll Pharm, Div Social & Adm Sci, Tucson, AZ 85721 USA
[3] Univ Arizona, Coll Pharm, Div HIV Policy & Outcomes Res, Tucson, AZ 85721 USA
关键词
D O I
10.1086/318492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purpose of this analysis was to examine the ability of the MOS-HIV (Medical Outcomes Study-Human Immunodeficiency Virus) Health Survey and the EuroQol Group's EQ-5D questionnaire to discriminate between subjects in predefined disease-severity groups on the basis of clinical-indicator status (i.e., CD4 cell counts, HIV type 1 [HIV-1] RNA copies). This study used medical records of and instruments completed by 242 HIV-infected patients. The ability of the health-related quality-of-life instruments to discriminate between subjects stratified by disease severity was assessed by means of receiver-operating characteristic (ROC) curve analysis. The EQ-5D (P < .05) and MOS-HIV physical health summary (PHS) scores (P < .01) were able to discriminate between groups of subjects stratified by disease severity on the basis of either CD4 cell counts or HIV-1 RNA copies. These findings provide further evidence of the validity of the use of EQ-5D and the MOS-HIV questionnaire and suggest that they may be practical tools for the monitoring of health status from the HIV-infected patient's perspective.
引用
收藏
页码:E47 / E52
页数:6
相关论文
共 29 条
[21]  
PALTIEL AD, 1996, QUALITY LIFE PHARMAC, P1053
[22]   Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV Health Survey [J].
Revicki, DA ;
Sorensen, S ;
Wu, AW .
MEDICAL CARE, 1998, 36 (02) :126-137
[23]  
REVICKI DA, 1997, 4 C RETR OPP INF WAS, P266
[24]   Impact of combination therapy for HIV infection on inpatient census [J].
Torres, RA ;
Barr, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21) :1531-1532
[25]   QUALITY-OF-LIFE IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - MEASUREMENT BY THE MEDICAL OUTCOMES STUDY INSTRUMENT [J].
WACHTEL, T ;
PIETTE, J ;
MOR, V ;
STEIN, M ;
FLEISHMAN, J ;
CARPENTER, C .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (02) :129-137
[26]   Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS [J].
Wu, AW ;
Hays, RD ;
Kelly, S ;
Malitz, F ;
Bozzette, SA .
QUALITY OF LIFE RESEARCH, 1997, 6 (06) :531-554
[27]   Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) [J].
Wu, AW ;
Revicki, DA ;
Jacobson, D ;
Malitz, FE .
QUALITY OF LIFE RESEARCH, 1997, 6 (06) :481-493
[28]   A HEALTH-STATUS QUESTIONNAIRE USING 30 ITEMS FROM THE MEDICAL OUTCOMES STUDY - PRELIMINARY VALIDATION IN PERSONS WITH EARLY HIV-INFECTION [J].
WU, AW ;
RUBIN, HR ;
MATHEWS, WC ;
WARE, JE ;
BRYSK, LT ;
HARDY, WD ;
BOZZETTE, SA ;
SPECTOR, SA ;
RICHMAN, DD .
MEDICAL CARE, 1991, 29 (08) :786-798
[29]  
ZWEIG MH, 1993, CLIN CHEM, V39, P561